A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.

MLA

Wodal, Walter, et al. “A Cell Culture-Derived Whole-Virus H9N2 Vaccine Induces High Titer Antibodies against Hemagglutinin and Neuraminidase and Protects Mice from Severe Lung Pathology and Weight Loss after Challenge with a Highly Virulent H9N2 Isolate.” Vaccine, vol. 30, no. 31, June 2012, pp. 4625–31. EBSCOhost, https://doi.org/10.1016/j.vaccine.2012.04.102.

APA

Wodal, W., Falkner, F. G., Kerschbaum, A., Gaiswinkler, C., Fritz, R., Kiermayr, S., Portsmouth, D., Savidis-Dacho, H., Coulibaly, S., Piskernik, C., Hohenadl, C., Howard, M. K., Kistner, O., Barrett, P. N., & Kreil, T. R. (2012). A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate. Vaccine, 30(31), 4625–4631. https://doi.org/10.1016/j.vaccine.2012.04.102

Chicago

Wodal, Walter, Falko G Falkner, Astrid Kerschbaum, Claudia Gaiswinkler, Richard Fritz, Stefan Kiermayr, Daniel Portsmouth, et al. 2012. “A Cell Culture-Derived Whole-Virus H9N2 Vaccine Induces High Titer Antibodies against Hemagglutinin and Neuraminidase and Protects Mice from Severe Lung Pathology and Weight Loss after Challenge with a Highly Virulent H9N2 Isolate.” Vaccine 30 (31): 4625–31. doi:10.1016/j.vaccine.2012.04.102.